New therapies finding their place in management of follicular lymphomaNovember 5, 2015Lymphoma & Plasma Cell DisordersFollicular Lymphoma
Lenalidomide plus rituximab achieves 87% response rateNovember 4, 2015Lymphoma & Plasma Cell DisordersMelanoma
Tomotherapy may decrease radiation-induced bowel toxicity in cervical cancerNovember 4, 2015Gynecologic Cancer
Commentary: Red meat and cancer risk – what your patients should knowNovember 3, 2015Preventive CareLung CancerGastroenterologyGastrointestinal Cancer
More evidence for extended ADT after radiation therapy for prostate cancer patientsNovember 3, 2015Genitourinary Cancer
Adjuvant lapatinib added no benefit against head and neck squamous cell carcinomaNovember 2, 2015Head & Neck/Thyroid Cancers
Adjuvant imatinib for 3 years better than 1 year in high-risk GISTNovember 2, 2015GastroenterologySarcoma & GISTGastrointestinal Cancer
ITC: Study provides first evidence of paclitaxel benefit for anaplastic thyroid cancerNovember 1, 2015Head & Neck/Thyroid Cancers
No link found between immunosuppression and anal dysplasia in IBDNovember 1, 2015GastroenterologyGastrointestinal Cancer
